Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,488 public trials 2,849 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, not recruiting

A Comparison of Reduced Dose Total Body Irradiation (TBI) and Cyclophosphamide With Fludarabine and Melphalan Reduced Intensity Conditioning in Adults With Acute Lymphoblastic Leukaemia (ALL) in Complete Remission. (ALL-RIC)

NCT03821610

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Heart of England Nhs Foundation Trust Birmingham, United Kingdom
  • University Hospitals Birmingham Nhs Foundation Trust Birmingham, United Kingdom
  • University Hospitals Bristol Nhs Foundation Trust Bristol, United Kingdom
  • Cambridge University Hospitals Nhs Foundation Trust Cambridge, United Kingdom
View all 22 locations
View Trial Details
Active, not recruiting

ACP-196 (Acalabrutinib), a Novel Bruton Tyrosine Kinase (BTK) Inhibitor, for Treatment of Chronic Lymphocytic Leukemia, Richter's Syndrome or Prolymphocytic Leukemia

NCT02029443

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +18 more
Locations
  • Research Site Boston, Massachusetts, United States
  • Research Site New Hyde Park, New York, United States
  • Research Site New York, United States
  • Research Site Columbus, Ohio, United States
View Trial Details
Active, not recruiting

A Trial of Treatments to Assess the Effects on Outcome of Adults With AML and MDS Undergoing Allogeneic SCT

NCT04217278

Conditions
Acute Myeloid Leukaemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations
  • Queen Elizabeth Hospital Birmingham, United Kingdom
  • University Hospitals Bristol Bristol, United Kingdom
  • Addenbrooke's Hospital Cambridge, United Kingdom
  • University Hospital of Wales Cardiff, United Kingdom
View all 14 locations
View Trial Details
Active, not recruiting

Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets

NCT05618028

Conditions
B Cell Malignancies, Chronic Disease, Chronic Lymphocytic Leukemia, +21 more
Locations
  • University of California Los Angeles Medical Center /ID# 246357 Los Angeles, California, United States
  • Yale University School of Medicine /ID# 259081 New Haven, Connecticut, United States
  • Mount Sinai Medical Center-Miami Beach /ID# 248251 Miami Beach, Florida, United States
  • Fort Wayne Medical Oncology and Hematology, Inc /ID# 250113 Fort Wayne, Indiana, United States
View all 39 locations
View Trial Details

Related conditions